Matok I - Search Results

1

Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.

Goldberg O, Koren G, Landau D, Lunenfeld E, Matok I, Levy A. Goldberg O, et al. Among authors: matok i. J Clin Pharmacol. 2013 Sep;53(9):991-5. doi: 10.1002/jcph.139. Epub 2013 Jul 20. J Clin Pharmacol. 2013. PMID: 23873250

2

Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis.

Adawi N, Rotshild V, Yanko S, Mowaswes M, Amir O, Haitner G, Matok I, Raccah BH. Adawi N, et al. Among authors: matok i. Front Cardiovasc Med. 2023 Jan 9;9:1016390. doi: 10.3389/fcvm.2022.1016390. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36698921 Free PMC article.

3

The safety of metoclopramide use in the first trimester of pregnancy.

Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. Matok I, et al. N Engl J Med. 2009 Jun 11;360(24):2528-35. doi: 10.1056/NEJMoa0807154. N Engl J Med. 2009. PMID: 19516033 Free article.

4

The safety of H(2)-blockers use during pregnancy.

Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Uziel E, Levy A. Matok I, et al. J Clin Pharmacol. 2010 Jan;50(1):81-7. doi: 10.1177/0091270009350483. Epub 2009 Sep 29. J Clin Pharmacol. 2010. PMID: 19789371

5

Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.

Matok I, Gorodischer R, Koren G, Landau D, Wiznitzer A, Levy A. Matok I, et al. Br J Clin Pharmacol. 2009 Dec;68(6):956-62. doi: 10.1111/j.1365-2125.2009.03544.x. Br J Clin Pharmacol. 2009. PMID: 20002091 Free PMC article.

6

Toward improved pregnancy labelling.

Koren G, Sakaguchi S, Klieger C, Kazmin A, Osadchy A, Yazdani-Brojeni P, Matok I. Koren G, et al. Among authors: matok i. J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e349-57. Epub 2010 Oct 26. J Popul Ther Clin Pharmacol. 2010. PMID: 21041868

7

Prenatal exposure to mycophenolate mofetil: an updated estimate.

Klieger-Grossmann C, Chitayat D, Lavign S, Kao K, Garcia-Bournissen F, Quinn D, Luo V, Sermer M, Riordan S, Laskin C, Matok I, Gorodischer R, Chambers C, Levi A, Koren G. Klieger-Grossmann C, et al. Among authors: matok i. J Obstet Gynaecol Can. 2010 Aug;32(8):794-7. doi: 10.1016/s1701-2163(16)34622-9. J Obstet Gynaecol Can. 2010. PMID: 21050513

8

Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis.

Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, Koren G. Kennedy DA, et al. Among authors: matok i. Cancer Epidemiol. 2011 Feb;35(1):2-10. doi: 10.1016/j.canep.2010.11.004. Epub 2010 Dec 21. Cancer Epidemiol. 2011. PMID: 21177150 Review.

9

BeMORE: a novel method for detection of adverse fetal effects induced by drugs.

Matok I, Levy A, Gorodischer R, Lunenfeld E, Limony Y, Koren G. Matok I, et al. Curr Drug Saf. 2011 Feb 1;6(1):40-2. doi: 10.2174/157488611794480052. Curr Drug Saf. 2011. PMID: 21241244

10

Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists.

Levy A, Matok I, Gorodischer R, Sherf M, Wiznitzer A, Uziel E, Koren G. Levy A, et al. Among authors: matok i. J Clin Pharmacol. 2012 Jan;52(1):78-83. doi: 10.1177/0091270010390806. Epub 2011 Feb 22. J Clin Pharmacol. 2012. PMID: 21343345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page